DEFUSE-3 Trial: Reinforcing Evidence for Extended Endovascular Intervention Time Window for Ischemic Stroke

The incidence of ischemic stroke in the United States is 3.29 per 1000 persons per year, making it the first and fourth greatest causes of disability and mortality, respectively.1 Previous randomized clinical trials (RCTs) investigating acute ischemic stroke (AIS) due to large-vessel occlusion (LVO) have shown that endovascular intervention is clinically beneficial when performed within 6 hours of onset.2-7 A few of these RCTs had perfusion imaging inclusion criteria, showing superior results when compared with similar RCTs without such criteria.
Source: World Neurosurgery - Category: Neurosurgery Authors: Tags: News and Opinion Source Type: research